Corentin Orvain

Angers, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications

Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia.

Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia.

Journal: Leukemia & lymphoma
Published: July 06, 2026

Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.

Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.

Journal: Leukemia
Published: May 21, 2026

Relationship Between Salvage Strategy and Outcomes in Patients With CBF or NPM1-mutated AML and First Molecular Relapse.

Relationship Between Salvage Strategy and Outcomes in Patients With CBF or NPM1-mutated AML and First Molecular Relapse.

Journal: Blood advances
Published: May 13, 2026

Allele burden expansion in JAK2 V617F and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment.

Allele burden expansion in JAK2 V617F and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment.

Journal: HemaSphere
Published: April 27, 2026

Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial.

Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial.

Journal: BMJ open
Published: March 19, 2026

Feasibility of tooth brushing during prolonged neutropenia in adults receiving intensive induction for acute leukemia: a randomized trial.

Feasibility of tooth brushing during prolonged neutropenia in adults receiving intensive induction for acute leukemia: a randomized trial.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 16, 2026

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Journal: HemaSphere
Published: November 26, 2025

Temporal trends and prognostic factors in critically ill adult patients with acute leukemia: an individual participant data meta-analysis.

Temporal trends and prognostic factors in critically ill adult patients with acute leukemia: an individual participant data meta-analysis.

Journal: Intensive care medicine
Published: November 07, 2025

Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Journal: American journal of hematology
Published: October 17, 2025

Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia.

Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 17, 2025

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms.

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms.

Journal: Annals of hematology
Published: September 10, 2025

Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.

Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.

Journal: The Lancet. Haematology
Published: August 18, 2025
Showing 1-12 of 120

Last Updated: 09/26/2026